Prices via Intrinio. Supplier and customer ties are extracted from SEC filings and carry the sentence they came from. Not investment advice.
Prices via Intrinio. Supplier and customer ties are extracted from SEC filings and carry the sentence they came from. Not investment advice.
Innoviva, Inc.
Price, suppliers and customers from SEC filings, institutional ownership and the next report.
Nasdaq · Pharmaceutical Preparations
Prev close 20.83 · gapped above the open, then crossed back over prior close. High/low 21.05 at 7:00 am ET, 20.63 at 10:00 am ET.
304 institutional managers report a position in Innoviva, Inc. worth $1.7B between them, filed on form 13F for the quarter ending 2026-06-30. 30 of them hold 80% of it, the largest being BlackRock, Inc. at 15.49%.
279 more managers in the register
30 managers hold 80% of the $1.7B institutional base. The other 274 hold the rest.
Positions as filed with the SEC for the quarter ended Jun 30. A 13F is due 45 days after the quarter closes, so this register is 78 days old and does not move with the price above it.
INVA (Innoviva, Inc.) has 10 disclosed suppliers and 3 disclosed customers, strongest disclosure first.
Suppliers:
Customers:
Select a tie for the filing sentence that discloses it; select again to open the company. Lines are disclosed suppliers and customers, coloured by industry; the closer to the centre, the more the filings disclose. A dot is green or red by today’s move. Extended: satellites hang off single companies, not bundled sectors.
Largest move on the map today: ARMP −2.27%, in healthcare.
via Boston Partners, Royce & Associates LP, Systematic Financial Management LP +11 more · 2.58% of INVA, 3.61% of AMN
via Systematic Financial Management LP, Boston Partners, Qube Research & Technologies Ltd +10 more · 2.71% of INVA, 2.34% of HLX
via Systematic Financial Management LP, Royce & Associates LP, Allianz Asset Management AG +10 more · 2.71% of INVA, 3.32% of UFCS
via Boston Partners, Royce & Associates LP, Qube Research & Technologies Ltd +6 more · 2.58% of INVA, 1.93% of ADTN
via Marshall Wace LLP, Systematic Financial Management LP, Royce & Associates LP +9 more · 1.95% of INVA, 3.76% of AMPH
via Boston Partners, Systematic Financial Management LP, Royce & Associates LP +5 more · 2.58% of INVA, 5.99% of NOMD
Managers holding a meaningful stake in INVA also hold this much of the other company’s institutional base. Managers who hold most of the companies we cover are excluded, because their overlap says nothing about this one in particular. This is how the two are held, not evidence that one moves the other.